565 related articles for article (PubMed ID: 26830416)
1. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
Moraes C; Borges NA; Mafra D
Eur J Nutr; 2016 Aug; 55(5):1813-21. PubMed ID: 26830416
[TBL] [Abstract][Full Text] [Related]
2. The Kidney-Gut Axis: Implications for Nutrition Care.
Rossi M; Johnson DW; Campbell KL
J Ren Nutr; 2015 Sep; 25(5):399-403. PubMed ID: 25812908
[TBL] [Abstract][Full Text] [Related]
3. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
[TBL] [Abstract][Full Text] [Related]
4. Could physical exercise help modulate the gut microbiota in chronic kidney disease?
Esgalhado M; Borges NA; Mafra D
Future Microbiol; 2016 May; 11():699-707. PubMed ID: 27159232
[TBL] [Abstract][Full Text] [Related]
5. Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.
Rasmussen HE; Hamaker B; Rajan KB; Mutlu E; Green SJ; Brown M; Kaur A; Keshavarzian A
Nutr Res; 2017 Aug; 44():27-37. PubMed ID: 28821315
[TBL] [Abstract][Full Text] [Related]
6. Toward a Personalized Approach in Prebiotics Research.
Dey M
Nutrients; 2017 Jan; 9(2):. PubMed ID: 28134778
[TBL] [Abstract][Full Text] [Related]
7. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.
Snelson M; Kellow NJ; Coughlan MT
Adv Nutr; 2019 Mar; 10(2):303-320. PubMed ID: 30668615
[TBL] [Abstract][Full Text] [Related]
9. The gut-kidney axis.
Evenepoel P; Poesen R; Meijers B
Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD).
Shamloo M; Mollard R; Wang H; Kingra K; Tangri N; MacKay D
Trials; 2022 Jan; 23(1):72. PubMed ID: 35073986
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and prebiotics modulation of uremic toxin generation.
Koppe L; Fouque D
Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
[TBL] [Abstract][Full Text] [Related]
13. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.
Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND
BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160
[TBL] [Abstract][Full Text] [Related]
14. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
[TBL] [Abstract][Full Text] [Related]
15. Improving healthspan via changes in gut microbiota and fermentation.
Keenan MJ; Marco ML; Ingram DK; Martin RJ
Age (Dordr); 2015 Oct; 37(5):98. PubMed ID: 26371059
[TBL] [Abstract][Full Text] [Related]
16. Prebiotics as a modulator of gut microbiota in paediatric obesity.
Nicolucci AC; Reimer RA
Pediatr Obes; 2017 Aug; 12(4):265-273. PubMed ID: 27072327
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.
Pan W; Kang Y
Int Urol Nephrol; 2018 Feb; 50(2):289-299. PubMed ID: 28849345
[TBL] [Abstract][Full Text] [Related]
18. Resistant starch can improve insulin sensitivity independently of the gut microbiota.
Bindels LB; Segura Munoz RR; Gomes-Neto JC; Mutemberezi V; Martínez I; Salazar N; Cody EA; Quintero-Villegas MI; Kittana H; de Los Reyes-Gavilán CG; Schmaltz RJ; Muccioli GG; Walter J; Ramer-Tait AE
Microbiome; 2017 Feb; 5(1):12. PubMed ID: 28166818
[TBL] [Abstract][Full Text] [Related]
19. A Renal Clinician's Guide to the Gut Microbiota.
Snelson M; Biruete A; McFarlane C; Campbell K
J Ren Nutr; 2020 Sep; 30(5):384-395. PubMed ID: 31928802
[TBL] [Abstract][Full Text] [Related]
20. Prebiotics and gut microbiota in chickens.
Pourabedin M; Zhao X
FEMS Microbiol Lett; 2015 Aug; 362(15):fnv122. PubMed ID: 26208530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
